Article Information
- March 2, 2021.
Author Information
- Andrew J Gangemi, MD1,*,†,
- Rohit Gupta, MBBS1,*,
- Gustavo Fernandez-Romero, MD1,
- Huaqing Zhao, PhD, MS2,
- Maulin Patel, MD1,
- Junad Chowdhury, MD1,
- Massa Zantah, MD1,
- Matthew Zheng, MD1,
- Osheen Abramian, MD7,
- Stephen Codella, MD1,
- Linda Vien, MD3,
- Eduardo Dominguez-Castillo, MD1,
- Timothy Buckey, MD3,
- Charles Earley, MD3,
- Jourdan Frankovich, MD3,
- Mali Jurkowski, MD3,
- Zachary Jurkowski, MD3,
- Jenny O’Brien, MD, PhD3,
- Nanzhou Guo, CRNP1,
- Paige Stanley, PA-C1,
- Brenton Halsey, MD, MA3,
- Jasleen Kahlon, MD3,
- Navjot Kaur, MD1,
- Roman Prosniak, MD1,
- Maruti Kumaran, MD, MBBS4,
- Chandra Dass, MBBS4,
- David Fleece, MD5,
- Michael R Jacobs, PharmD1,6,
- Gerard J. Criner, MD1 and
- on behalf of the Temple University COVID-19 Research Group
- 1Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 2Department of Clinical Sciences, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 3Department of Internal Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 4Department of Radiology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 5Department of Clinical Pediatrics, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 6Department of Pharmacy Practice, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- 7Department of Pulmonary and Interventional Pulmonary Medicine, Lewis Katz School of Medicine, Cooper University Hospital, Camden, NJ, Lewis Katz School of Medicine at Temple University, Philadelphia, PA
- ↵†Corresponding Author:
Andrew J. Gangemi, MD, Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, 3401 North Broad Street, 7th Floor Parkinson Pavilion, Philadelphia, PA 19140, Phone: 215-663-9095, Fax: 215-663-8408, Email: Andrew.Gangemi{at}tuhs.temple.edu
↵* Contributed Equally
Author Contributions: AJG and RG were primarily responsible for project planning, data collection and interpretation, and drafting the manuscript. GFR, MZ, MZ, OA, SC, LV, EDC, TB, CE, JF, MJ, ZJ, JO, NG, PS, BH, JK, NK, and RP participated in data collection. HZ assisted with statistical analysis. MK, CD, DF, and MRJ helped with creation of the severity scoring and maintenance of COVID-19 database. GJC was primarily responsible for creation of the severity score, resource planning during the pandemic, and oversight of the project and manuscript.